ReviewFrontiers in oncology2022

RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?

Kurt Sartorius et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.